SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DanZ who wrote (4693)10/11/2003 5:06:10 PM
From: StockDung   of 5582
 
Re: defending Zicam! I love it! eom
by: makemilns (38/M) 01/04/01 05:18 pm
Msg: 43063 of 83791

There is no question whether Cold Eeze and Zicam are effective against the common cold. There is no question whether Zicam is nearly twice as effective as Cold Eeze with less side effects. The only question is one of marketing.

Speaking of marketing, the manufacturer of Zinc Up can not claim that their product reduces the duration of the symptoms of the common cold, or has any effect against the common cold for that matter, without sufficient clinical proof to that effect. If they try to use the clinical data for Zicam, then it is obvious that their product infringes on the Zicam patent. So in my opinion, either they are violating Gel Tech's patent or violating FTC regulations, either of which could result in their product being removed from the shelf.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News